Search Results - "Fruscio R"

A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.

Authors: Fruscio, R Colombo, N Lissoni, A A et al.

Source: British Journal of Cancer. 2/26/2008, Vol. 98 Issue 4, p720-727. 8p. 6 Charts, 2 Graphs.

Artificial intelligence (AI) weights the importance of factors predicting malignancy at the time of ultrasonographic (US) examination.

Authors: Chiappa, V. Fruscio, R. Franchi, D. et al.

Source: Australasian Journal of Ultrasound in Medicine. May2019, Vol. 22 Issue 2, p143-143. 1p.

Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series.

Authors: Fruscio, R. Corso, S. Ceppi, L. et al.

Source: Annals of Oncology. Jan2013, Vol. 24 Issue 1, p138-144. 7p.

Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer.

Authors: Fruscio R Garbi A Parma G et al.

Source: JNCI: Journal of the National Cancer Institute. Feb2011, Vol. 103 Issue 4, p347-351. 5p.

Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery.

Authors: Assi, F. Fruscio, R. Bonardi, C. et al.

Source: BJOG: An International Journal of Obstetrics & Gynaecology. Feb2007, Vol. 114 Issue 2, p143-147. 5p. 2 Charts, 1 Graph.

The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer.

Authors: Guffanti, F. Fruscio, R. Rulli, E. et al.

Source: Scientific Reports. 12/2/2016, p38142. 1p.

Imaging in gynecological disease (29): clinical and ultrasound features of primary ovarian immature teratoma.

Authors: Landolfo, C. Froyman, W. Testa, A. C. et al.

Source: Ultrasound in Obstetrics & Gynecology. Jan2026, Vol. 67 Issue 1, p89-99. 11p.

DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer.

Authors: Caiola, E Porcu, L Fruscio, R et al.

Source: Pharmacogenomics Journal. Apr2013, Vol. 13 Issue 2, p159-172. 14p. 7 Charts, 4 Graphs.

Long-term development of 12- and 15-year-old offspring after maternal cancer diagnosis during pregnancy: a prospective multicentre cohort study.

Authors: Huis in 't Veld, E.A. Van Assche, I.A. Van Calsteren, K. et al.

Source: Annals of Oncology. Sep2025, Vol. 36 Issue 9, p1025-1034. 10p.

OP03.09: Artificial intelligence (AI) weights the importance of factors predicting malignancy at the time of ultrasonographic (US) examination.

Authors: Chiappa, V. Fruscio, R. Franchi, D. et al.

Source: Ultrasound in Obstetrics & Gynecology. Oct2018 Supplement S1, Vol. 52, p74-74. 1p.

OP17.07: Doppler evaluation of wall shear rate (WSR), wall distension rate (WDR), turbulence index (TI) in preoperative ovarian cysts: A prospective study.

Authors: Urban, G. Fruscio, R. Beretta, P. et al.

Source: Ultrasound in Obstetrics & Gynecology. Aug2008, Vol. 32 Issue 3, p370-370. 1p.

Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA‐1 multinomial regression model: validation study.

Authors: Heremans, R. Wynants, L. Valentin, L. et al.

Source: Ultrasound in Obstetrics & Gynecology. Apr2024, Vol. 63 Issue 4, p556-563. 8p.

A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment.

Authors: Calura, E. Paracchini, L. Fruscio, R. et al.

Source: Annals of Oncology. Aug2016, Vol. 27 Issue 8, p1511-1519. 9p. 2 Diagrams, 2 Charts, 1 Graph.

Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.

Authors: Beltrame, L. Di Marino, M. Fruscio, R. et al.

Source: Annals of Oncology. Jul2015, Vol. 26 Issue 7, p1363-1371. 9p. 1 Diagram, 3 Charts, 3 Graphs.

Lung cancer in pregnancy: Report of nine cases from an international collaborative study.

Authors: Boussios, S. Han, S.N. Fruscio, R. et al.

Source: Lung Cancer (01695002). Dec2013, Vol. 82 Issue 3, p499-505. 7p.

Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumors.

Authors: Franchi, D. Boveri, S. Fruscio, R. et al.

Source: Ultrasound in Obstetrics & Gynecology. Apr2013, Vol. 41 Issue 4, p452-458. 7p.

Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests.

Authors: Daemen, A. Valentin, L. Fruscio, R. et al.

Source: Ultrasound in Obstetrics & Gynecology. Jan2011, Vol. 37 Issue 1, p100-106. 7p.

Benign descriptors and ADNEX in two‐step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort.

Authors: Landolfo, C. Bourne, T. Froyman, W. et al.

Source: Ultrasound in Obstetrics & Gynecology. Feb2023, Vol. 61 Issue 2, p231-242. 12p.

Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3).

Authors: Heremans, R. Van Den Bosch, T. Valentin, L. et al.

Source: Ultrasound in Obstetrics & Gynecology. Aug2022, Vol. 60 Issue 2, p243-255. 13p.

Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study.

Authors: Testa, A Kaijser, J Wynants, L et al.

Source: British Journal of Cancer. 8/1/2014, Vol. 111 Issue 4, p680-688. 9p. 5 Charts, 2 Graphs.